AlloStim (bioengineered allogeneic immune cells) / Immunovative 
Welcome,         Profile    Billing    Logout  

4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AlloStim (bioengineered allogeneic immune cells) / Immunovative
ALIVE, NCT05033522: Immunotherapy for Advanced Liver Cancer

Recruiting
2/3
150
RoW
AlloStim® immunotherapy, FOLFOX regimen, Physician Choice FOLFOX4, Sorafenib, Sorafenib Physician's Choice, Lenvatinib, Levantinib Physician's Choice
Mirror Biologics, Inc., Immunovative (Thailand) Co., Ltd
Hepatocellular Carcinoma
08/25
12/25
STIMVAX, NCT04444622: Immunotherapy for Third Line Metastatic Colorectal Cancer

Recruiting
2
24
US
AlloStim, StimVax
Mirror Biologics, Inc., Mirror Biologics, Inc.
Metastatic Colorectal Cancer
11/24
04/25
COMUNITY, NCT06557278: Combined AlloStim+Anti-PD-L1 in 4L MSS Metastatic Colorectal Cancer

Not yet recruiting
2
50
US
AlloStim, Bavencio, Avelumab
Mirror Biologics, Inc.
Metastatic Colorectal Cancer
06/25
11/25
ALLOPRIME, NCT04441047: Universal Anti-Viral Vaccine for Healthy Elderly Adults

Completed
1/2
40
US
AlloStim
Immunovative Therapies, Ltd., Mirror Biologics, Inc.
Virus Diseases, Pneumonia, COVID-19 Respiratory Infection, RSV Pneumonia, Influenza, Human, ARDS, Human
03/23
04/23

Download Options